Top Markets
#1 DogBull DogBull +54.48%
#2 Siren Siren +30.82%
#3 OriginTrail OriginTrail +17.82%
#4 Yield Basis Yield Basis +14.21%
#5 龙虾 (Lobster) 龙虾 (Lobster) +11.05%
#6 Cysic Cysic +9.48%
#7 COTI COTI +8.70%
#8 Purr Purr +8.26%
#9 Stargate Finance Stargate Finance +7.94%
#10 MetYa MetYa +7.11%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Rank in Stocks #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Share Price
$0.3479
Last synced: 2024-08-21
Market Cap
$94.92M
Change (1 day)
0.64%
Change (1 year)
0.00%
Country
US
Trade Asensus Surgical, Inc. (ASXC)

Category

Healthcare
Operating Margin for Asensus Surgical, Inc. (ASXC)
Operating Margin as of August 2026 TTM: -926.52%
According to Asensus Surgical, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -926.52%. At the end of 2022 the company had an Operating Margin of -1,067.86%.
Operating Margin history for Asensus Surgical, Inc. from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -926.52% 0.00%
2023 -926.52% -13.24%
2022 -1,067.86% 36.04%
2021 -784.97% -58.73%
2020 -1,902.02% 4.97%
2019 -1,811.92% 788.50%
2018 -203.93% -76.58%
2017 -870.86% -89.30%
2016 -8,140.16% 0.00%
2015 0.00% -100.00%
2014 -9,129.43% 410.24%
2013 -1,789.24% 468.63%
2012 -314.66% 0.00%
2011 0.00% -100.00%
2010 18,431.03% 0.00%
2009 0.00% 0.00%
2008 0.00% -100.00%
2007 2,052.59% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% -100.00%
2003 -462.77% 1,370.04%
2002 -31.48% 842.51%
2001 -3.34% -265.35%
2000 2.02% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.02%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.02%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.02%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.02%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.